Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 60760-883

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

883-90 (Atorvastatin 60760 883 90)

Label for Atorvastatin Calcium 20 mg film-coated tablets, USP, with a quantity of 90 tablets. The label includes the NDC number 60760-883-90 and indicates the product is manufactured by Hetero Labs Limited, India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. Storage instructions specify controlled room temperature (15°-30°C). Lot number and expiration date fields are blank.*

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium, depicting its molecular composition including calcium ions and associated functional groups.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph depicting cumulative incidence (%) over time in years, comparing Atorvastatin and placebo groups. The plot shows two lines: one solid line for Atorvastatin and one dashed line for placebo, highlighting differences in incidence rates with hazard ratio (HR) and p-value annotations.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line chart depicting cumulative hazard percentage over time (years) for placebo versus atorvastatin. The x-axis shows time to first primary endpoint through four years of follow-up, while the y-axis shows cumulative hazard in percent. The chart compares hazard rates, with atorvastatin showing a lower cumulative hazard than placebo, including a hazard ratio (HR) of 0.63 (0.48-0.83) and a p-value of 0.001.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line graph comparing the time to first major cardiovascular endpoint over five years between atorvastatin 10 mg and atorvastatin 80 mg doses. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event, with hazard ratio and p-value noted.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.